MRK
Merck & Company, Inc.
Drug Manufacturers - General · Healthcare · United States
135.55
close · 2026-08-13
value
53
cheaper than peers53
quality
66
stronger fundamentals66
ranked against
Healthcare
value
quality
374 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 14.20× | 70 |
| EV to EBITDA | 12.38× | 66 |
| price to book | 7.98× | 28 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 38.6% | 96 |
| return on equity | 18.9% | 83 |
| revenue growth | 4.9% | 31 |
| debt to equity | 106.9% | 23 |
4 of 4 measures available
Facts
| market cap | $334B |
| free cash flow | $14.05B |
| employees | 73,000 |
| first trade | 1962-01-02 |
| next earnings | 2026-10-29 |
| fundamentals updated | 2026-07-30 |